JPH0433224B2 - - Google Patents

Info

Publication number
JPH0433224B2
JPH0433224B2 JP1171535A JP17153589A JPH0433224B2 JP H0433224 B2 JPH0433224 B2 JP H0433224B2 JP 1171535 A JP1171535 A JP 1171535A JP 17153589 A JP17153589 A JP 17153589A JP H0433224 B2 JPH0433224 B2 JP H0433224B2
Authority
JP
Japan
Prior art keywords
container
solution
drug
infusion
container according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP1171535A
Other languages
Japanese (ja)
Other versions
JPH0337067A (en
Inventor
Masuyoshi Kosaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HISHAMA SEIYAKU KK
Original Assignee
HISHAMA SEIYAKU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HISHAMA SEIYAKU KK filed Critical HISHAMA SEIYAKU KK
Priority to JP1171535A priority Critical patent/JPH0337067A/en
Publication of JPH0337067A publication Critical patent/JPH0337067A/en
Publication of JPH0433224B2 publication Critical patent/JPH0433224B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Description

【発明の詳細な説明】 <産業上の利用分野> 本発明は輸液容器に関し、詳しくはバイアル等
の容器に入つた粉末薬剤などを使用直前に無菌的
に溶解することのできる輸液容器に関する。
DETAILED DESCRIPTION OF THE INVENTION <Industrial Application Field> The present invention relates to an infusion container, and more particularly to an infusion container in which a powdered drug or the like contained in a container such as a vial can be dissolved aseptically immediately before use.

<従来の技術> 病院等の医療機関においては、従来より、バイ
アル等の容器に入つた粉末薬剤あるいは凍結乾燥
薬剤を溶解して輸液として点滴治療に用いている
が、薬剤の溶解操作は、上記薬剤の入つた容器と
その薬剤を溶かす溶解液の入つた容器とを両頭針
あるいは連結管等の接続用具を用いて接続し、溶
解液を薬剤の入つた容器に移すことにより行つて
いる。ところがこの操作は煩雑で手間がかかる上
に、薬剤の入つた容器に接続するための穴を明け
る操作を外気中で行うので、中の薬剤が汚染され
る虞がある。
<Prior art> In hospitals and other medical institutions, powdered or freeze-dried drugs in containers such as vials have been dissolved and used as infusions for intravenous drip therapy. This is done by connecting a container containing a drug and a container containing a solution for dissolving the drug using a connecting tool such as a double-ended needle or a connecting tube, and transferring the solution to the container containing the drug. However, this operation is complicated and time-consuming, and since the hole for connecting to the container containing the drug is performed in the open air, there is a risk that the drug inside may be contaminated.

そこで上記のような問題を解消するものとし
て、特表昭61−501129号公報に示されるような輸
液容器が提案されている。
Therefore, in order to solve the above-mentioned problems, an infusion container as shown in Japanese Patent Publication No. 1983-501129 has been proposed.

この輸液容器は第11図に示されるように、薬
剤の入つたバイアル301を収容するカプセル3
02と、薬液取出口を有する溶解液の入つた可撓
性容器303とが、チユーブ304で接続された
ものである。そしてチユーブ304内には、薬剤
バイアル301側に中空の穿刺針305が取り付
けられ、可撓性容器303側に破断部材306が
取り付けられている。この破断部材306はチユ
ーブ304内の通路を閉じており、液体の流通を
阻止している。
As shown in FIG. 11, this infusion container includes a capsule 3 containing a vial 301 containing a drug.
02 and a flexible container 303 containing a solution having a drug solution outlet are connected by a tube 304. Inside the tube 304, a hollow puncture needle 305 is attached to the drug vial 301 side, and a breaking member 306 is attached to the flexible container 303 side. This breaking member 306 closes the passage within the tube 304 and prevents fluid flow.

使用に際しては、カプセル302上部のキヤツ
プ307を指で押してバイアル301を押し下
げ、穿刺針305でバイアル301のゴム栓30
8を貫き、可撓性容器303とバイアル301と
をまず連結する。ついで、チユーブ304内の破
断部材306を手で折つてチユーブ304内の通
路を開通させ、薬剤と溶解液とを混合するように
なつている。
In use, press the cap 307 at the top of the capsule 302 with your finger to push down the vial 301, and insert the rubber stopper 30 of the vial 301 with the puncture needle 305.
8 to first connect the flexible container 303 and the vial 301. Then, the breakable member 306 in the tube 304 is manually broken to open a passage in the tube 304 and mix the drug and the solution.

<発明が解決しようとする課題> しかしながら、前記輸液容器において、薬剤の
容器と溶解液の容器とを連通して混合するという
点に関しては、改良されたとは言うものの、穿刺
針305によつてバイアル301のゴム栓308
を刺通したのち、破断部材306を手で折つて通
路を開けなければならず、まだかなり手間を要す
るものである。また破断部材306の折れ方が不
完全なばあいは、液が通りにくく、溶解に時間が
かかるという欠点がある。さらに破断部材306
の破断片が可撓性容器303内に残置されるた
め、点滴治療中の患者に対し不必要な精神的不安
を与えるという欠点もある。
<Problems to be Solved by the Invention> However, although the infusion container has been improved in that the drug container and the solution container are communicated with each other for mixing, the puncture needle 305 does not allow the vial to be 301 rubber stopper 308
After piercing the hole, the breaking member 306 must be broken by hand to open the passage, which still requires considerable effort. In addition, if the breakable member 306 is imperfectly bent, there is a disadvantage that it is difficult for the liquid to pass through and it takes time to dissolve. Furthermore, the breaking member 306
There is also the drawback that the broken pieces of the phlegm are left in the flexible container 303, causing unnecessary mental anxiety to the patient undergoing infusion therapy.

本発明はかかる事情に鑑みてなされたもので、
薬剤容器と溶解液や稀釈液(以下、溶解液とい
う)の容器との連通を確実かつ容易にし、連通後
の薬剤と溶解液の混合を短時間で行うことができ
る輸液容器を提供することを目的とする。
The present invention was made in view of such circumstances,
To provide an infusion container that enables reliable and easy communication between a drug container and a container for a dissolution solution or dilution solution (hereinafter referred to as dissolution solution), and allows mixing of the drug and the solution in a short time after communication. purpose.

<課題を解決するための手段> 本発明は上記の課題を解決するために、薬剤容
器を収容する熱可塑性樹脂製袋体と、該袋体に倒
立状態で収容される、口部が中空針で刺通可能な
栓体で密封された薬剤容器と、中空針で刺通可能
な閉鎖膜によつてその液体通路が閉鎖された連通
部と、該連通部の反対側に薬液の取出口とを具
え、内部に溶解液または稀釈液が収容された溶解
液容器と、前記袋体に連通接続されるとともに、
前記溶解液容器の連通部に接続される柔軟な筒状
体と、前記袋体に収容されかつ少なくともその一
部が該筒状体に軸方向にのみ移動可能に挿入され
ており、前記薬剤容器と溶解液容器の間にあつて
該2つの容器の内部を連通する中空針のみからな
る又は内部に中空針を設けた連通手段と、前記薬
剤容器と溶解液容器とを所定の間隔を置いて支持
固定するため両容器を連通接続する筒状体の外部
に嵌着した着脱自在な容器支持手段とからなる薬
剤の無菌的な溶解または稀釈を可能とする輸液容
器を採用している。
<Means for Solving the Problems> In order to solve the above-mentioned problems, the present invention provides a thermoplastic resin bag for accommodating a drug container, and a needle with a hollow opening that is housed in the bag in an inverted state. A drug container sealed with a stopper that can be pierced by a hollow needle, a communication part whose liquid passage is closed by a closure membrane that can be penetrated by a hollow needle, and a drug solution outlet on the opposite side of the communication part. a dissolving solution container containing a dissolving solution or a diluting solution therein, and a dissolving solution container that is communicatively connected to the bag body;
a flexible cylindrical body connected to the communication portion of the solution container; a flexible cylindrical body housed in the bag body and at least a portion of which is inserted into the cylindrical body so as to be movable only in the axial direction; and a communication means consisting only of a hollow needle or having a hollow needle provided therein, which is located between the drug container and the solution container and communicates the insides of the two containers, and the drug container and the solution container are placed at a predetermined interval. An infusion container is used that enables aseptic dissolution or dilution of drugs, and includes a removable container support means fitted to the outside of a cylindrical body that communicates and connects both containers for support and fixation.

<作用> 上記構成によれば、使用に際して、輸液容器か
ら容器支持手段を外すことにより、薬剤容器と溶
解液容器とは互いに接近可能にならる。そこで薬
剤容器と連通手段である中空針を手で把持し、ま
ず薬剤容器を下降させて薬剤容器の栓体に中空針
の一方の刃先を刺通し、それから中空針を持つて
いた手で溶解液容器を把持し薬剤容器をさらに下
降させて溶解液容器の連通部に中空針の他方の刃
先を刺通すれば、薬剤容器と溶解液容器とは連通
手段を介して連通するので、溶解液容器から薬剤
容器に溶解液を導入して薬剤容器中の薬剤を容易
にかつ無菌的に溶かすことができる。
<Function> According to the above configuration, in use, by removing the container support means from the infusion container, the medicine container and the solution container can become close to each other. Therefore, grasp the hollow needle, which is the communication means with the drug container, with your hand, first lower the drug container and pierce one cutting edge of the hollow needle through the stopper of the drug container, and then use the hand that was holding the hollow needle to hold the solution solution container. If the other cutting edge of the hollow needle is inserted into the communicating part of the solution container by grasping the drug container and further lowering the drug container, the drug container and solution container will communicate with each other through the communication means, so that the solution container can be removed from the solution container. By introducing a dissolving liquid into the drug container, the drug in the drug container can be easily and aseptically dissolved.

<実施例> 次に本発明の実施例について図面に基づいて説
明する。
<Example> Next, an example of the present invention will be described based on the drawings.

第1図は本発明の一実施例に係る輸液容器の要
部断面図であり、第2図は容器支持手段の実施例
の正面図、第3図は第2図のA−A線断面図、第
4図および第7図は容器支持手段の他の実施例を
示す断面図および斜視図、第5図および第6図は
それぞれ第4図に示す容器支持手段のB−B線断
面図およびC−C線断面図である。また第8図は
連通手段の実施例を示す断面図、第9図は溶解液
容器の実施例を示す説明図、第10図は溶解液容
器の他の実施例を示す説明図である。
FIG. 1 is a sectional view of essential parts of an infusion container according to an embodiment of the present invention, FIG. 2 is a front view of an embodiment of the container support means, and FIG. 3 is a sectional view taken along the line A-A in FIG. 2. , FIGS. 4 and 7 are sectional views and perspective views showing other embodiments of the container support means, and FIGS. 5 and 6 are sectional views taken along line B-B of the container support means shown in FIG. It is a sectional view taken along the line CC. 8 is a sectional view showing an embodiment of the communication means, FIG. 9 is an explanatory diagram showing an embodiment of the solution container, and FIG. 10 is an explanatory diagram showing another embodiment of the solution container.

第1図に示すように本発明の輸液容器は熱可塑
性樹脂の袋体1と、この袋体1内に収容された薬
剤容器2、溶解液が収容された溶解液容器3、袋
体1と溶解液容器3の間に介在して両者を接続す
る筒状体4、薬剤容器2と溶解液容器3を連通す
る連通手段5、および薬剤容器2と溶解液容器3
とを所定の間隔を置いて支持する着脱自在な容器
支持手段6からなつている。
As shown in FIG. 1, the infusion container of the present invention includes a thermoplastic resin bag 1, a drug container 2 housed in the bag 1, a solution container 3 containing a solution, and the bag 1. A cylindrical body 4 that is interposed between the solution container 3 and connects the two, a communication means 5 that communicates the drug container 2 and the solution container 3, and a drug container 2 and the solution container 3.
It consists of removable container support means 6 that supports the container at a predetermined interval.

以下、各部分について詳細に説明する。 Each part will be explained in detail below.

袋体1は熱可塑性樹脂の例えばポリエチレンや
ポリプロピレン、軟質塩化ビニル樹脂、エチレン
ビニルアセテートなどで形成されており、中に収
容された薬剤容器2をカバーしてこれを無菌的に
保護するためのものである。そして袋体1の端
部、溶解液容器3と反対側の端部には懸架手段と
してのハンガー穴7が設けられている。懸架手段
としては他にフツク状のものや紐なども使用可能
である。尚、袋体1は、ポリプロピレンやポリエ
ステルなどのガラス製薬剤容器2に付着しにくい
フイルムで作られた袋体1の場合には必ずしも必
要としないが、一般に、薬剤容器2との付着を防
止するために、その内面を粗面に形成したり、そ
の内面に縦方向の微細な突条を形成したりする必
要がある。
The bag body 1 is made of thermoplastic resin such as polyethylene, polypropylene, soft vinyl chloride resin, ethylene vinyl acetate, etc., and is used to cover and protect the drug container 2 housed therein in a sterile manner. It is. A hanger hole 7 serving as a suspension means is provided at the end of the bag 1, the end opposite to the solution container 3. Other suspension means such as hooks and strings can also be used. Although the bag 1 is not necessarily required in the case of a film made of a film such as polypropylene or polyester that does not easily adhere to the glass drug container 2, it is generally necessary to prevent the bag from adhering to the drug container 2. Therefore, it is necessary to make the inner surface rough or to form fine longitudinal ridges on the inner surface.

薬剤容器2は袋体1内に倒立状態で収容される
もので、内部に血液製剤などの凍結乾燥薬剤や抗
生物質、抗癌剤などの粒状または粉末状の薬剤が
収容されており、その口部は中空針で刺通するこ
とのできる栓体8で密封されている。容器そのも
のはガラスまたはポリエチレンやポリプロピレン
などの耐薬品性の優れた合成樹脂で製せられてお
り、栓体8はゴム状弾性体で製せられている。ゴ
ム状弾性体としてはエチレン−プロピレンゴムや
ブチルゴム、ニトリルゴム、アクリルゴムなどが
耐薬品性が優れており好ましく使用される。
The drug container 2 is stored in an inverted state within the bag body 1, and contains granular or powdered drugs such as freeze-dried drugs such as blood products, antibiotics, and anticancer drugs. It is sealed with a stopper 8 that can be pierced with a hollow needle. The container itself is made of glass or a synthetic resin with excellent chemical resistance such as polyethylene or polypropylene, and the stopper 8 is made of a rubber-like elastic material. As the rubbery elastic material, ethylene-propylene rubber, butyl rubber, nitrile rubber, acrylic rubber, etc. are preferably used because they have excellent chemical resistance.

溶解液容器3は内部に生理食塩水や5%ブドウ
糖液、注射用蒸留水などの溶解液または稀釈液が
収容されたもので、前記薬剤容器2と連通される
部分である連通部9と、一般にこの連通部9と反
対側の端部に設けられる薬液取出口10とを具備
しており、容器そのものは一般に熱可塑性樹脂で
袋体またはボルト状に形成される。連通部9は袋
体1側に突設された液体通路11を閉鎖膜12で
閉鎖してなるものである。第9図は袋状の溶解液
容器の一実施例であり、同図において溶解液容器
31の上端には薄い閉鎖膜121によつてその液
体通路111が閉鎖された連通部91が、下端に
は薬液取出口101が設けられている。また第1
0図はボトル状の溶解液容器の一実施例であり、
溶解液容器32には第9図と同様に液体通路11
2が閉鎖膜122で閉鎖された連通部92と薬液
取出口102が設けられている。
The solution container 3 contains a solution or dilution solution such as physiological saline, 5% glucose solution, or distilled water for injection, and has a communication portion 9 that communicates with the drug container 2; Generally, the container is provided with a drug solution outlet 10 provided at the end opposite to the communication portion 9, and the container itself is generally formed of thermoplastic resin into a bag or bolt shape. The communication portion 9 is formed by closing a liquid passage 11 protruding from the bag body 1 side with a closing membrane 12. FIG. 9 shows an embodiment of a bag-shaped solution container, in which a communication portion 91 whose liquid passage 111 is closed by a thin closure membrane 121 is provided at the upper end of the solution container 31, and at the lower end thereof. A chemical solution outlet 101 is provided. Also the first
Figure 0 is an example of a bottle-shaped solution container,
The solution container 32 has a liquid passage 11 as shown in FIG.
2 is provided with a communication portion 92 closed by a closure membrane 122 and a drug solution outlet 102.

筒状体4は袋体1に連通するように接続される
とともに、溶解液容器3の連通部9の外壁に接続
される柔軟な部分であり、筒の軸方向すなわち第
1図において上下方向に伸縮自在な蛇腹状のもの
や、ポリエチレンやポリプロピレン、ポリエステ
ル、塩化ビニル樹脂などの合成樹脂のシートまた
はフイルムからなるチユーブ状のものなどが採用
される。但し筒状体4の上部および下部のみ柔軟
に形成したものであつてもよい。従つて、筒状体
4がシートまたはフイルムのチユーブの場合に
は、袋体の下部を窄めて実質的に筒状に形成する
ことにより筒状体4を袋体1と一体に形成しても
よい。尚、筒状体4の内面には連通手段の滑りを
良くするために、微細な突条を形成したり、その
内面を粗面に形成したりするのが好ましい。
The cylindrical body 4 is a flexible part that is connected to the bag body 1 so as to communicate therewith, and is also connected to the outer wall of the communication part 9 of the solution container 3, and extends in the axial direction of the cylinder, that is, in the vertical direction in FIG. A flexible bellows-like material or a tube-like material made of a sheet or film of synthetic resin such as polyethylene, polypropylene, polyester, or vinyl chloride resin are used. However, only the upper and lower parts of the cylindrical body 4 may be formed to be flexible. Therefore, when the cylindrical body 4 is a sheet or a film tube, the cylindrical body 4 can be formed integrally with the bag 1 by narrowing the lower part of the bag to form a substantially cylindrical shape. Good too. Incidentally, in order to improve the sliding of the communication means on the inner surface of the cylindrical body 4, it is preferable to form fine protrusions or to form the inner surface into a rough surface.

連通手段5は薬剤容器2と溶解液容器3の間に
配置されており、この2つの容器2,3の内部を
連通するためのものである。連通手段5は袋体1
に収容されるとともに、少なくともその一部が筒
状体4に挿入されており、この筒状体4の軸方向
にのみ移動可能になつている。連通手段5として
は、単に両端に刃先を有する中空な針(以下、両
頭針という)のみを使用してもいいが、両頭針1
3とこの針13をその中央付近で支持し固定する
ハブ14からなるものや、これをさらに薬剤容器
2および連通部9を案内するガイド15,16を
設けたもの(第1図参照)、さらにこのガイド付
連通手段の刃先にゴムキヤツプ17を冠着したも
の(第8図参照)などが好ましい。合成樹脂製の
連通手段5の場合には両頭針13とハブ14を一
体に形成することも可能である。また両頭針13
には流体通路が1つのものと2つのものがあるが
流体通路が2つのものの方が薬液をスムーズに移
行させることができ好ましい。第8図に示す連通
手段51はゴムキヤツプ17付のものであり、1
31は両頭針、141はハブ、151は連通部ガ
イド、161はバイアスガイド、23は連通部側
の刃先である。尚、連通手段5の形成材料は、一
般に両頭針13についてはステンレスや合成樹脂
であり、ハブ14については合成樹脂である。そ
して合成樹脂としては一般にポリプロピレンやア
クリロニトリル−ブタジエン−スチレン共重合体
(ABS樹脂)、ポリカーボネートなどが使用され
る。
The communication means 5 is arranged between the medicine container 2 and the solution container 3, and is for communicating the insides of these two containers 2 and 3. The communication means 5 is the bag body 1
At least a portion thereof is inserted into the cylindrical body 4, and is movable only in the axial direction of the cylindrical body 4. As the communication means 5, only a hollow needle having cutting edges at both ends (hereinafter referred to as a double-ended needle) may be used, but the double-ended needle 1
3 and a hub 14 that supports and fixes the needle 13 near its center, and one that is further provided with guides 15 and 16 that guide the drug container 2 and the communication portion 9 (see Fig. 1); It is preferable that a rubber cap 17 is attached to the cutting edge of this guided communication means (see FIG. 8). In the case of the communication means 5 made of synthetic resin, it is also possible to form the double-ended needle 13 and the hub 14 integrally. Also, double-ended needle 13
There are two types: one with one fluid passage and one with two fluid passages, but the one with two fluid passages is preferable because it allows the chemical solution to transfer smoothly. The communication means 51 shown in FIG. 8 is equipped with a rubber cap 17.
31 is a double-ended needle, 141 is a hub, 151 is a communicating portion guide, 161 is a bias guide, and 23 is a cutting edge on the communicating portion side. The communication means 5 is generally made of stainless steel or synthetic resin for the double-ended needle 13, and synthetic resin for the hub 14. As the synthetic resin, polypropylene, acrylonitrile-butadiene-styrene copolymer (ABS resin), polycarbonate, etc. are generally used.

容器支持手段6は薬剤容器2と溶解液容器3と
を所定の間隔、すなわち薬剤容器2の栓体8およ
び溶解液容器3の連通部9に連通手段5が接触し
ないように、決められた間隔を置いて支持し固定
するための着脱自在な支持具であり、一般に発泡
スチロールなどのプラスチツクフオームや、ポリ
エチレン、ポリプロピレン、ポリスチレン、塩化
ビニル樹脂などの熱可塑性樹脂で製せられるが、
金属や木材、厚紙などで形成してもよい。そして
少なくとも容器支持部分すなわち袋体1や筒状体
4の上から薬剤容器2や溶解液容器3を挾んで支
持する部分は、横断面形状が略C字状に形成され
ており、このC字の開裂部分(第2〜3図の2
2、第4〜6図の221、第7図の222)から
薬剤容器2や溶解液容器3に容器支持手段6を押
し込んで嵌着すればよい。容器支持手段6として
は第2〜3図に示すようなプラスチツクフオーム
で作られたものや、第4〜6図に示すような熱可
塑性樹脂で筒状に作られたもの、第7図に示すよ
うなC字状のリングを支柱で繋げたものなどが挙
げられる。
The container support means 6 holds the drug container 2 and the solution container 3 at a predetermined distance, that is, at a predetermined distance so that the communication means 5 does not come into contact with the stopper 8 of the drug container 2 and the communication portion 9 of the solution container 3. It is a removable support for placing, supporting, and fixing objects, and is generally made of plastic foam such as expanded polystyrene, or thermoplastic resin such as polyethylene, polypropylene, polystyrene, and vinyl chloride resin.
It may be formed of metal, wood, cardboard, etc. At least the container supporting portion, that is, the portion that supports the drug container 2 and the solution container 3 from above the bag body 1 and the cylindrical body 4, has a cross-sectional shape that is approximately C-shaped. cleavage part (2 in Figures 2 and 3)
2. The container support means 6 may be inserted into the medicine container 2 or solution container 3 by pushing it into the drug container 2 or solution container 3 from 221 in FIGS. 4 to 6 or 222 in FIG. 7. The container support means 6 may be made of plastic foam as shown in FIGS. 2-3, cylindrical from thermoplastic resin as shown in FIGS. 4-6, or cylindrical as shown in FIG. An example is a C-shaped ring connected by a support.

第2図の容器支持手段61は発泡スチロールや
発泡ポリウレタン、発泡ポリエチレンなどで筒状
に形成されており、バイアル支持部18と連通部
支持部19を有している。第3図は第2図のA−
A線断面図であり、断面形状は略C字状になつて
いる。
The container support means 61 shown in FIG. 2 is formed into a cylindrical shape from foamed polystyrene, foamed polyurethane, foamed polyethylene, etc., and has a vial support portion 18 and a communication portion support portion 19. Figure 3 is A- in Figure 2.
It is a cross-sectional view taken along line A, and the cross-sectional shape is approximately C-shaped.

第4図の容器支持手段62はポリエチレンやポ
リプロピレン、ポリスチレン、ポリエステル、塩
化ビニル樹脂などの熱可塑性樹脂で筒状に形成さ
れており、バイアル支持部181とハブ支持部2
0および連通部支持部191を有している。第5
図及び第6図はそれぞれ第4図のB−B線および
C−C線断面図であり、断面形状は略C字状にな
つている。
The container support means 62 in FIG. 4 is formed into a cylindrical shape from a thermoplastic resin such as polyethylene, polypropylene, polystyrene, polyester, or vinyl chloride resin, and includes a vial support portion 181 and a hub support portion 2.
0 and a communication portion support portion 191. Fifth
The figure and FIG. 6 are cross-sectional views taken along the lines B--B and C--C in FIG. 4, respectively, and the cross-sectional shape is approximately C-shaped.

第7図の容器支持手段63は第4図におけるも
のと同様の熱可塑性樹脂で形成されており、開裂
部分222を有するリング状のバイアル支持部1
82と連通部支持部192およびハブ支持部20
1が支柱21で連接されたものである。
The container support means 63 in FIG. 7 is made of thermoplastic resin similar to that in FIG.
82, the communication portion support portion 192, and the hub support portion 20
1 are connected by struts 21.

次に本輸液容器の使用方法について説明する。 Next, how to use this infusion container will be explained.

輸液容器の使用に際しては、まず輸液容器から
容器支持手段6を取り外し、次いで薬剤容器2と
連通手段5とを袋体1および筒状体4の上から手
で把持しながら、薬剤容器2を連通手段5側に移
動させて、連通手段5の両頭針13の一方の刃先
で薬剤容器2の栓体8を刺通する。次に溶解液容
器3を連通部9の付け根部分で把持しながら、連
通手段5で刺通された薬剤容器2を溶解液容器3
側に移動させて、連通部9の閉鎖膜12を両頭針
13の他方の刃先で刺通する。以上の操作で薬剤
容器2と溶解液容器3とが連通されるので、溶解
液容器3を手で圧迫して薬剤容器2に溶解液を移
行させると、薬剤容器2の薬剤は溶解液で溶解さ
れる。こうして薬液が製剤されたら、連通手段5
の両頭針13が2つの流体通路を有するものであ
る場合には、輸液容器をハンガー穴7を利用して
ハンガー(図示していない)などに架けると、薬
液は重力により自然に溶解液容器3に移行する。
但し両頭針13の流体通路が1つの場合には溶解
液容器3を手で揉むように圧迫しながら薬液を移
行させる必要がある。尚、必要ならば薬液を薬剤
容器2に移行させ溶解液容器3に戻す操作を繰り
返してもよい。
When using the infusion container, first remove the container support means 6 from the infusion container, and then connect the drug container 2 to the communication means 5 while holding the drug container 2 and the communication means 5 by hand from above the bag body 1 and the cylindrical body 4. It is moved to the means 5 side, and the stopper 8 of the medicine container 2 is pierced with one cutting edge of the double-ended needle 13 of the communication means 5. Next, while grasping the solution container 3 at the base of the communication part 9, the drug container 2 pierced by the communication means 5 is inserted into the solution container 3.
The double-ended needle 13 is moved to the side, and the other cutting edge of the double-ended needle 13 is pierced through the obturator membrane 12 of the communicating portion 9 . With the above operation, the drug container 2 and the solution container 3 are communicated with each other, so when the solution container 3 is pressed by hand to transfer the solution to the drug container 2, the drug in the drug container 2 is dissolved in the solution. be done. After the medicinal solution is prepared in this way, the communication means 5
When the double-ended needle 13 has two fluid passages, if the infusion container is hung on a hanger (not shown) using the hanger hole 7, the drug solution will naturally flow into the solution container 3 due to gravity. to move to.
However, when the double-ended needle 13 has only one fluid passage, it is necessary to transfer the medicinal solution while pressing the dissolving solution container 3 by hand as if kneading it. Note that, if necessary, the operation of transferring the drug solution to the drug container 2 and returning it to the solution container 3 may be repeated.

<発明の効果> 以上説明してきたことから明らかなように本発
明の輸液容器は次のような利点を有する。
<Effects of the Invention> As is clear from the above explanation, the infusion container of the present invention has the following advantages.

(1) 容器支持手段を設けたことにより、輸液容器
を使用しない時には、確実に薬剤容器と溶解液
容器を一定間隔を置いて支持し連通しないよう
に分離させ、使用時には確実かつ容易に薬剤と
溶解液とを混合することができる。
(1) By providing a container support means, when the infusion container is not in use, the drug container and the solution container are supported at a certain interval and separated so that they do not communicate with each other, and when in use, the drug container and solution container can be reliably and easily separated. It can be mixed with a solution.

(2) 薬剤溶器を熱可塑性樹脂製袋体に収容するこ
とにより、薬剤容器を無菌的に保護し、かつこ
の袋体と筒状体との連通接続により薬剤と溶解
液とを無菌的に混合することができる。
(2) By accommodating the drug dissolver in a thermoplastic resin bag, the drug container is protected aseptically, and the drug and solution are sterilized by the communication between the bag and the cylindrical body. Can be mixed.

(3) 連通後の薬剤と溶解液の混合を短時間で行う
ことができる。
(3) After communication, the drug and solution can be mixed in a short time.

(4) 従来の類似品に比べ全体にサイズを小型にす
ることが可能である。
(4) The overall size can be made smaller than conventional similar products.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明の一実施例に係る輸液容器の要
部断面図であり、第2図は容器支持手段の実施例
の正面図、第3図は第2図のA−A線断面図、第
4図は容器支持手段の他の実施例を示す断面図、
第5図は第4図に示す容器支持手段のB−B線断
面図、第6図は第4図に示す容器支持手段のC−
C線断面図、第7図は容器支持手段の他の実施例
を示す斜視図である。また第8図は連通手段の実
施例を示す断面図、第9図は溶解液容器の実施例
を示す説明図、第10図は溶解液容器の他の実施
例を示す説明図である。また第11図は従来の類
似の輸液容器を説明する図である。 <主な符号の説明>、1:袋体、2:薬剤容
器、3,31,32:溶解液容器、4:筒状体、
5,51:連通手段、6,61,62,63:容
器支持手段、7:ハンガー穴、9,91,92:
連通部、10,101,102:薬液取出口、1
1,111,112:液体通路、12,121,
122:閉鎖膜、13,131:両頭針、14,
141:ハブ、15,151:連通部ガイド、1
6,161:バイアルガイド、17:ゴムキヤツ
プ。
FIG. 1 is a sectional view of essential parts of an infusion container according to an embodiment of the present invention, FIG. 2 is a front view of an embodiment of the container support means, and FIG. 3 is a sectional view taken along the line A-A in FIG. 2. , FIG. 4 is a sectional view showing another embodiment of the container support means,
5 is a sectional view taken along the line B-B of the container support means shown in FIG. 4, and FIG. 6 is a cross-sectional view taken along the line C--
A sectional view taken along line C and FIG. 7 are perspective views showing another embodiment of the container support means. 8 is a sectional view showing an embodiment of the communication means, FIG. 9 is an explanatory diagram showing an embodiment of the solution container, and FIG. 10 is an explanatory diagram showing another embodiment of the solution container. FIG. 11 is a diagram illustrating a similar conventional infusion container. <Explanation of main symbols>, 1: Bag body, 2: Drug container, 3, 31, 32: Solution container, 4: Cylindrical body,
5, 51: Communication means, 6, 61, 62, 63: Container support means, 7: Hanger hole, 9, 91, 92:
Communication part, 10, 101, 102: Chemical solution outlet, 1
1,111,112: Liquid passage, 12,121,
122: Obturator membrane, 13, 131: Double-ended needle, 14,
141: Hub, 15, 151: Communication part guide, 1
6,161: Vial guide, 17: Rubber cap.

Claims (1)

【特許請求の範囲】 1 薬剤容器を収容する熱可塑性樹脂製袋体と、
該袋体に倒立状態で収容される、口部が中空針で
刺通可能な栓体で密封された薬剤容器と、 中空針で刺通可能な閉鎖膜によつてその液体通
路が閉鎖された連通部と、該連通部の反対側に薬
液の取出口とを具え、内部に溶解液または稀釈液
が収容された溶解液容器と、 前記袋体に連通接続されるとともに、前記溶解
液容器の連通部に接続される柔軟な筒状体と、 前記袋体に収容されかつ少なくともその一部が
該筒状体に軸方向にのみ移動可能に挿入されてお
り、前記薬剤容器と溶解液容器の間にあつて該2
つの容器の内部を連通する中空針のみからなる又
は内部に中空針を設けた連通手段と、 前記薬剤容器と溶解液容器とを所定の間隔を置
いて支持固定するため両容器を連通接続する筒状
体の外部に嵌着した着脱自在な容器支持手段とか
らなる薬剤の無菌的な溶解または稀釈を可能とす
る輸液容器。 2 袋体と筒状体の内面が粗面に形成されてなる
請求項1記載の輸液容器。 3 袋体と筒状体の内面の縦方向に微細な突条が
形成されてなる請求項1記載の輸液容器。 4 容器支持手段が薬剤容器の口部および溶解液
容器の連通部に袋体の上から嵌着される、少なく
ともその容器支持部分の横断面形状が略C字状の
支持具である請求項1ないし3のいずれか1項に
記載の輸液容器。 5 容器支持手段が可撓性樹脂で形成されてなる
請求項4記載の輸液容器。 6 容器支持手段がプラスチツクフオームで形成
されてなる請求項4記載の輸液容器。 7 溶解液容器が熱可塑性樹脂で製せられた袋体
である請求項1ないし6のいずれか1項に記載の
輸液容器。 8 溶解液容器がプラスチツクボトルである請求
項1ないし6のいずれか1項に記載の輸液容器。 9 閉鎖膜が連通部と別体に形成されてなる請求
項7または8に記載の輸液容器。 10 閉鎖膜が連通部と一体に形成されてなる請
求項7または8に記載の輸液容器。 11 連通部が溶解液容器と一体に形成されてな
る請求項10記載の輸液容器。 12 連通手段が中間にハブを有し両端に刃先を
有する中空針である請求項1ないし3のいずれか
1項に記載の輸液容器。 13 溶解液容器側の針部分の少なくとも刃先部
分にゴムキヤツプが被冠されてなる請求項12記
載の輸液容器。 14 薬剤容器の栓体および溶解液容器の連通部
が中空針によつて確実に刺通されるように、ハブ
にガイド手段を設けてなる請求項12または13
に記載の輸液容器。 15 中空針が熱可塑性樹脂で製せられてなる請
求項12ないし14のいずれか1項に記載の輸液
容器。 16 中空針が金属で製せられてなる請求項12
ないし14のいずれか1項に記載の輸液容器。 17 筒状体が袋体と一体に形成されてなる請求
項1ないし3のいずれか1項に記載の輸液容器。
[Claims] 1. A thermoplastic resin bag housing a drug container;
A drug container was housed in the bag in an inverted state, and the opening was sealed with a stopper that could be pierced with a hollow needle, and the liquid passageway was closed by a closure membrane that could be pierced with a hollow needle. A solution container having a communication part and a drug solution outlet on the opposite side of the communication part and containing a solution or a dilution solution therein; a flexible cylindrical body connected to the communication portion; a flexible cylindrical body housed in the bag and at least a part of which is movably inserted into the cylindrical body only in the axial direction; Part 2 in between
a communication means consisting only of a hollow needle or having a hollow needle provided therein, communicating the insides of the two containers; and a cylinder communicating and connecting the drug container and the solution container in order to support and fix the two containers at a predetermined interval. An infusion container capable of aseptically dissolving or diluting a drug, comprising a removable container support means fitted to the outside of the container. 2. The infusion container according to claim 1, wherein the inner surfaces of the bag body and the cylindrical body are formed into rough surfaces. 3. The infusion container according to claim 1, wherein fine protrusions are formed in the longitudinal direction on the inner surfaces of the bag body and the cylindrical body. 4. Claim 1, wherein the container support means is a support that is fitted into the opening of the drug container and the communication portion of the solution container from above the bag, and whose cross-sectional shape at least at the container support portion is substantially C-shaped. The infusion container according to any one of items 3 to 3. 5. The infusion container according to claim 4, wherein the container support means is made of flexible resin. 6. The infusion container according to claim 4, wherein the container support means is formed of plastic foam. 7. The infusion container according to any one of claims 1 to 6, wherein the solution container is a bag made of thermoplastic resin. 8. The infusion container according to any one of claims 1 to 6, wherein the solution container is a plastic bottle. 9. The infusion container according to claim 7 or 8, wherein the closure membrane is formed separately from the communication portion. 10. The infusion container according to claim 7 or 8, wherein the closure membrane is formed integrally with the communication portion. 11. The infusion container according to claim 10, wherein the communication portion is formed integrally with the solution container. 12. The infusion container according to any one of claims 1 to 3, wherein the communication means is a hollow needle having a hub in the middle and cutting edges at both ends. 13. The infusion container according to claim 12, wherein at least the cutting edge of the needle on the side of the solution container is covered with a rubber cap. 14. Claim 12 or 13, wherein the hub is provided with a guide means so that the hollow needle can reliably pierce the stopper of the drug container and the communicating portion of the solution container.
The infusion container described in . 15. The infusion container according to any one of claims 12 to 14, wherein the hollow needle is made of thermoplastic resin. 16 Claim 12 wherein the hollow needle is made of metal.
15. The infusion container according to any one of items 1 to 14. 17. The infusion container according to any one of claims 1 to 3, wherein the cylindrical body is formed integrally with the bag body.
JP1171535A 1989-07-03 1989-07-03 Transfusion container Granted JPH0337067A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1171535A JPH0337067A (en) 1989-07-03 1989-07-03 Transfusion container

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1171535A JPH0337067A (en) 1989-07-03 1989-07-03 Transfusion container

Publications (2)

Publication Number Publication Date
JPH0337067A JPH0337067A (en) 1991-02-18
JPH0433224B2 true JPH0433224B2 (en) 1992-06-02

Family

ID=15924926

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1171535A Granted JPH0337067A (en) 1989-07-03 1989-07-03 Transfusion container

Country Status (1)

Country Link
JP (1) JPH0337067A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK210592A3 (en) * 1990-11-07 1994-01-12 Otsuka Pharma Co Ltd Reservoir with a large number of chambers
JPH05103819A (en) * 1991-08-08 1993-04-27 Nissho Corp Medicine receiving container
CA2093560C (en) * 1992-04-10 2005-06-07 Minoru Honda Fluid container
JP2605345Y2 (en) * 1992-05-01 2000-07-10 株式会社大塚製薬工場 Drug container
JPH0686738U (en) * 1992-06-16 1994-12-20 森下ルセル株式会社 Medical container
JPH06239352A (en) * 1993-02-05 1994-08-30 Nissho Corp Solution injection set
JPH0717311Y2 (en) * 1993-02-26 1995-04-26 稔郎 古川 Chemical solution container
JP2555163Y2 (en) * 1993-03-25 1997-11-19 昭和電工株式会社 Infusion container
JP3493198B2 (en) * 1993-06-28 2004-02-03 味の素ファルマ株式会社 Medical container
CA2166552A1 (en) * 1993-07-23 1995-02-02 Leonard T. Chapman Camera pedestal
JP2004166847A (en) * 2002-11-18 2004-06-17 Otsuka Pharmaceut Factory Inc Drip preparation apparatus, mixing tube, liquid medicine receptacle, liquid mixture receptacle, drip preparation system, and preparation method for drip

Also Published As

Publication number Publication date
JPH0337067A (en) 1991-02-18

Similar Documents

Publication Publication Date Title
US3788369A (en) Apparatus for transferring liquid between a container and a flexible bag
US7207969B2 (en) Direct dual filling device for sealing agents
CA1316821C (en) Sterilizable system for blood storage
JP4930772B2 (en) Communicating needle used to communicate two or more containers
US4637934A (en) Liquid container with integral opening apparatus
US6358236B1 (en) Device for reconstituting medicaments for injection
US4583971A (en) Closed drug delivery system
AU636060B2 (en) Sheath for cannula
JPH06239352A (en) Solution injection set
JPH05212090A (en) Transfusion container
JPH0236261B2 (en)
JPH08126683A (en) Container for transfusion
KR20060019567A (en) Reconstitution device and method of use
JP2005246083A (en) Port adapter, protector, and container with them
WO1986005683A1 (en) Transfer device
BRPI0612571A2 (en) integrated infusion container
JPH0433224B2 (en)
US5669502A (en) Vial holder
JP2004329685A (en) Medical solution filling device and medical solution filling system
JP3003949B2 (en) Medical container
JP3415714B2 (en) Chemical transfer device and chemical transfer system
JP2710414B2 (en) Injection solution dissolver
JPH077965Y2 (en) Infusion bag
JPH0642675Y2 (en) Medical bag
JPH04329955A (en) Germ-free holding/mixing apparatus for two kinds of medicines held in individually sealed container